IMMERSION CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that IMMERSION CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $10.87M | Feb 27, 2019 |
| FY2018 | Sep 30, 2018 | $8.55M | Feb 27, 2019 |
| FY2018 | Jun 30, 2018 | $6.14M | Feb 27, 2019 |
| FY2018 | Mar 31, 2018 | $85.42M | Feb 27, 2019 |
| FY2018 | Dec 31, 2017 | $6.90M | Feb 27, 2019 |
| FY2018 | Sep 30, 2017 | $11.86M | Feb 27, 2019 |
| FY2018 | Jun 30, 2017 | $7.03M | Feb 27, 2019 |
| FY2018 | Mar 31, 2017 | $9.22M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $9.29M | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $26.31M | Feb 27, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.56B | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $471.26M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $616.25M | Mar 12, 2026 |
| FY2025 | Jul 31, 2024 | $89.94M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $95.48M | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $45.78M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $33.92M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $38.46M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $35.09M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $30.46M | Feb 25, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $11.41M | Mar 6, 2020 |
| FY2019 | Sep 30, 2019 | $10.56M | Mar 6, 2020 |
| FY2019 | Jun 30, 2019 | $8.70M | Mar 6, 2020 |
| FY2019 | Mar 31, 2019 | $5.11M | Mar 6, 2020 |
| FY2019 | Dec 31, 2018 | $10.84M | Mar 6, 2020 |
| FY2019 | Sep 30, 2018 | $8.49M | Mar 6, 2020 |
| FY2019 | Jun 30, 2018 | $6.05M | Mar 6, 2020 |
| FY2019 | Mar 31, 2018 | $85.38M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $6.86M | Feb 27, 2019 |
| FY2018 | Sep 30, 2017 | $11.80M | Feb 27, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $64.28M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $24.06M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $30.80M | Mar 12, 2026 |
| FY2025 | Jul 31, 2024 | ($246.0K) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $26.45M | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $17.78M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $33.98M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $30.66M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $12.48M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $5.40M | Feb 25, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $118.02M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $35.24M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $70.43M | Mar 12, 2026 |
| FY2025 | Jul 31, 2024 | ($9.64M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $22.62M | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $16.03M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $17.93M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $24.42M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $17.78M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.22M | Feb 25, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $281.0K | Mar 11, 2024 |
| FY2023 | Dec 31, 2022 | $1.38M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $4.15M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $5.01M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $7.84M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $9.73M | Mar 6, 2020 |
| FY2019 | Dec 31, 2017 | $11.76M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $13.39M | Feb 27, 2019 |
| FY2017 | Dec 31, 2015 | $14.79M | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $11.79M | Mar 3, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($57.58M) | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | ($107.67M) | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | ($63.98M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | ($56.03M) | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $31.60M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $20.60M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $40.15M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $17.45M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $22.0K | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($34.10M) | Mar 5, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $11.24M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $8.13M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $5.59M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $928.0K | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $0 | Mar 12, 2026 |
| FY2022 | Dec 31, 2022 | $30.0K | Feb 22, 2023 |
| FY2022 | Dec 31, 2021 | $335.0K | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $47.0K | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $150.0K | Mar 5, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.10B | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $1.44B | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $1.36B | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $1.23B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $215.73M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $190.11M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $175.52M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $96.13M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $124.85M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $146.00M | Mar 6, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $543.58M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $849.97M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $876.60M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $819.93M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $32.63M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $32.41M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $34.23M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $32.15M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $41.09M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $46.34M | Mar 6, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $298.13M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $317.95M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $305.50M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $273.40M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $183.10M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $157.70M | Mar 11, 2024 |
| FY2023 | Dec 31, 2021 | $141.30M | Mar 11, 2024 |
| FY2022 | Dec 31, 2020 | $63.98M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $83.76M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $99.66M | Mar 5, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2023 | $0 | Mar 12, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $34.69M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $53.86M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $38.10M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $9.06M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($36.04M) | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | ($70.02M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($100.68M) | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | ($113.16M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($118.57M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($98.52M) | Mar 6, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $72.61M | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $85.52M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $56.07M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $48.82M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $51.49M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $59.52M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $86.48M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $110.99M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $24.62M | Feb 27, 2019 |
| FY2018 | Dec 31, 2016 | $56.87M | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $103.10M | Mar 12, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 1 | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jul 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Feb 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 1 | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jul 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Feb 25, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 32.50M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | 32.40M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | 48.69M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 31.96M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 31.53M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | 32.25M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 34.39M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 27.02M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 31.41M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | 30.83M | Mar 6, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $12.85M | Mar 12, 2026 |
| FY2025 | Jan 31, 2025 | $11.34M | Mar 12, 2026 |
| FY2025 | Oct 31, 2024 | $3.04M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $2.99M | Mar 12, 2026 |
| FY2025 | Apr 30, 2024 | $2.99M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $7.41M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $0 | Mar 11, 2024 |